Outcome measures in juvenile X-linked retinoschisis: A systematic review

Eye (Lond). 2020 Oct;34(10):1760-1769. doi: 10.1038/s41433-020-0848-6. Epub 2020 Apr 20.

Abstract

X-linked retinoschisis (XLRS) is a leading cause of hereditary juvenile macular degeneration in males resulting in significant vision impairment. Outcome measures to monitor disease progression or therapeutic interventions have evolved with technology. A systematic review was undertaken to evaluate outcome measures for XLRS. Inclusion criteria were all publications examining outcome measures for natural history studies or following an interventional approach for patients with XLRS. Studies which did not present follow-up data were excluded. We searched medical databases including CENTRAL, Ovid Medline, pre-Medline and ahead of Print up to February 2019. Two authors independently assessed the risk of bias. Twelve studies meet the inclusion criteria with four prospective and eight retrospective case series. Five series were natural history observational studies and seven were interventional series using either topical or systemic carbonic anhydrase inhibitors. Visual acuity (VA) declined very slowly in the natural history studies equivalent to 0.22-0.5 letters per year. Five of the six interventional studies showed an improvement in VA and four a reduction in spectral domain optical coherence tomography (SD-OCT) parameters for central macular thickness (CMT). The full-field electroretinogram identified the 30-Hz latency as a further parameter to monitor function. VA was the measure most likely to show a statistically significant outcome. How functionally meaningful this is, requires further evaluation. CMT SD-OCT outcomes are variable depending on cystic changes. More refined measures are required to better correlate structure with function.

摘要: X连锁视网膜劈裂症 (X-linked retinoschisis, XLRS) 是一种男性遗传性青少年黄斑变性并可造成视力严重损害的疾病。监测疾病进展或治疗干预的临床指标随技术的发展而进步。本文对XLRS的临床预后指标进行了系统回顾。本文纳入了所有发表的, 针对XLRS的自然病程进行研究或对患者进行干预研究的文章, 并排除无随访数据的研究。我们检索了CENTRAL、Ovid Medline、pre-Medline医疗数据库, 搜索截至2019年2月前发表或预发表的文章。由两位作者独立评估偏倚风险。共有12项研究符合纳入标准, 其中4项为前瞻性研究, 8项为回顾性研究。5项为自然病程观察性研究, 7项为局部或全身应用碳酸酐酶抑制剂干预治疗。在自然病程研究中, 视力下降非常缓慢, 相当于每年下降0.22-0.5 个字母。六项干预性研究中有五项显示视力改善, 四项SD检查(spectral domain optical coherence tomography, SD-OCT)显示黄斑中心厚度降低。全视野视网膜电流图将30Hz刺激下的潜伏期作为进一步功能监测的参数。视力是最有可能显示统计学意义的预后指标, 在功能检测的意义方面, 还需要进一步评估。黄斑中心厚度的SD-OCT结果取决于囊腔的改变程度。现需要更精细的、能够更好地结合结构与功能的监测指标的预后评估方法。.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Humans
  • Male
  • Outcome Assessment, Health Care
  • Prospective Studies
  • Retinoschisis* / genetics
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Visual Acuity